Meanwhile, the S&P BSE Sensex rose 216.27 points, or 0.65%, to settle at 33,462.97.

The stock listed at Rs 237 on BSE, a discount of 4.43% compared with the issue price of Rs 248 per share. The stock had hit a high of Rs 254.65 and a low of Rs 236.15 in intraday trade. On the BSE, 18.05 lakh shares were traded on the counter.

The initial public offer (IPO) of Shalby had received bids for 4.08 crore shares, data on NSE showed. The IPO was subscribed 2.82 times. The price band of the IPO was Rs 245 to Rs 248 per share. The IPO opened for subscription on 5 December 2017 and closed on 7 December 2017.

Category wise, the qualified institutional buyers (QIBs) category was subscribed 4.34 times. The non institutional investors (NIIs) category was subscribed 0.42 times. The retail individual investors (RIIs) category was subscribed 2.98 times.

Ahead of the opening of the IPO, the IPO committee of the board of directors of the company at its meeting held on 4 December 2017, finalized allocation of 60.7 lakh equity shares to 13 anchor investors at Rs 248 per share.

On a consolidated basis, the company reported net profit of Rs 14.39 crore on total income of Rs 90.60 crore in Q1 June 2017.

Shalby is one of the leading multi-specialty chain of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialization such as orthopedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.